Transcriptional activation of hTERT in breast carcinomas by the Her2-ER81-related pathway

Oncology Research

Volumn 17, Issue 9, 2009, Pages 413-423

  Vageli, Dimitra ^a   Ioannou, Maria G ^a   Koukoulis, George K ^a  

^a UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

ER81; Her2; hTERT; Q RT real time PCR

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR ER81; DNA BINDING PROTEIN; ERBB2 PROTEIN, HUMAN; ETV1 PROTEIN, HUMAN; MESSENGER RNA; TELOMERASE; TERT PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TRANSCRIPTION INITIATION; BREAST TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENETICS; MIDDLE AGED; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; RECEPTOR, ERBB-2; RNA, MESSENGER; SIGNAL TRANSDUCTION; TELOMERASE; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 70349768601     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504009788912507     Document Type: Article

References (29)

1. Harley, C. B. ; Futcher, A. B.; Greider, C. W. Telomeres shorten during ageing of human fibroblasts. Nature 345(6274):458-460; 1990.
2. Soria, J. C.; Gauthier, L.; Raymond, E.; et al. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients. Clin. Cancer Res. 5: 971-975; 1999.
3. Hoos, A.; Hepp, H. H.; Kaul, S.; et al. Telomerase activity correlates with tumor agressiveness and reflects therapy effect in breast cancer. Int. J. Cancer 79:8-12; 1998.
4. Poremba, C.; Heine,B.; Diallo, R.; et al. Telomerase as a prognostic marker in broast cancer high-throughput tissue microarray analysis of hTERT and hTR. J. Pathol. 198: 181-189; 2002.
5. Krupp, G.; Klapper, W.; Parwaresch, R. Cell proliferation, carcinogenesis and diverse mechanisms of telomerase regulation. CMLS Cell Mol. Life Sci. 57:464-486; 2000.
6. Bieche, I.; Nogues, C.; Paradis, V.; et al. Quantification of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin. Cancer Res. 6:452-459; 2000.
7. Hiyama, E.; Saeki, T.; Hiyama, K.; et al. Telomerase activity as a marker of breast carcinoma in fine-needle aspirated samples. Cancer Cytopathol. 90:235-238; 2000.
8. Yoshiba, K.; Toge, T. Telomerase activity in gastrointestinal, bladder and breast carcinomas and their clinical applications. Nippon Rinsho 62(7):1368-1376; 2004.
9. Kirkpatrick, K. L.; Clark, G.; Ghilchick, M.; et al. hTERT mRNA expression correlates with telomerase activity in human breast cancer. Eur. J. Surg. Oncol. 29:321-326; 2003.
10. Yano, Y.; Yoshida, K.; Osaki, A.; et al. Expression and distribution of telomerase catalytic component, hTERT, in human breast tissues. Anticancer Res. 22:4101-4107; 2002.
11. Ducrest, A. L.; Amacker, M.; Mathieu, Y. D.; et al. Regulation of human telomerase activity: Repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity. Cancer Res. 61(20):7594-7602; 2001.
12. Horikawa, I.; Cable, P. L.; Mazur, S. J.; et al. Downstream E-box-mediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: Evidence for an endogenous mechanism of transcriptional expression. Mol. Biol. Cell 13(8):2585-2597; 2002.
13. Goueli, B. S.; Janknecht, R. Upregulation of the catalytic telomerase subunit by the transcription factor ER81 and oncogenic HER2/Neu, Ras, or Raf. Mol. Cell. Biol. 24: 25-35; 2004.
14. Chang, L.; Karin, M. Mammalian MAP kinase signalling cascades. Nature 410(6824):37-40; 2001.
15. Bosc, D. G.; Goueli, B. S.; Janknecht, R. HER2/Neu- mediated activation of the ETS transcription factor ER81 and its target gene MMP-1. Oncogene 20(43):6215-6224; 2001.
16. Janknecht, R. Analysis of the ERK-stimulated ETS transcription factor ER81. Mol. Cell. Biol. 16(4):1550-1556; 1996.
17. Shepherd, T. G.; Kockeritz, L.; Szrajber, M. R.; et al. The pea3 subfamily ets genes are required for HER2/Neu- mediated mammary oncogenesis. Curr. Biol. 11(22): 1739-1748; 2001.
18. Ben-Levy, R.; Paterson, H. P.; Marshall, C. J.; et al. A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway. EMBO J. 13:3302-3311; 1994.
19. Hynes, N. E.; Stern, D. F. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim. Biophys. Acta 1198:165-184; 1994.
20. McCarthy, S. A.; Chen, D.; Yang, B. S.; et al. Rapid phosphorylation of Ets-2 accompanies mitogen-activated growth factor gene expression by oncogenic Raf-1. Mol. Cell. Biol. 17:2401-2412; 1997.
21. Yang, B. S.; Hauser, C. A.; Henkel, G.; et al. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol. Cell. Biol. 16:538-547; 1996.
22. O'Hagan, R. C.; Tozer, R. G.; Symans, M.; et al. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades. Oncogene 13(6):1323-1333; 1996.
23. Treisman, R. Regulation of transcription by MAP kinase 4 cascades. Curr. Opin. Cell Biol. 8(2):205-215; 1996.
24. Benz, C. C.; O'Hagan, R. C.; Richter, B.; et al. HER2/Neu and Ets transcription activator PEA3 are coordinately up-regulated in human breast cancer. Oncogene 15:1513-1525; 1997.
25. Goel, A.; Janknecht, R. Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/neu. J. Biol. Chem. 279(15):14909-14916; 2004.
26. Poole, J. C.; Andrews, L. G.; Tollefsbol, T. O. Activity, function, and gene regulation of the catalytic subunit of telomerse (hTERT). Gene 269:1-2; 2001.
27. Lin, S. Y.; Elledge, S. J. Multiple tumor supressor pathways negatively regulate telomerase. Cell 113:881-889; 2003.
28. Hines, W. C.; Fajardo, A. M.; Joste, N. E.; et al. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues. Mol. Cancer Res. 3(9):503-509; 2005.
29. Elmore, L. W.; Forsythe, H. L.; Ferreira-Gonzlez, A.; et al. Real-time quantitative analysis of telomerase activity in breast tumor specimens using a highly specific and sensitive fluorescent-based assay. Diagn. Mol. Pathol. 11(3): 177-185; 2002.